Tci Wealth Advisors, Inc. Bluebird Bio, Inc. Transaction History

Tci Wealth Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$2.94 - $5.23 $2,481 - $4,414	-844 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$4.07 - $10.6 $3,435 - $8,946	844 New	844 $4,000
Q4 2021 Jan 24, 2022	SELL	$8.96 - $16.31 $2,858 - $5,202	-319 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$11.24 - $21.0 $2,281 - $4,263	203 Added 175.0%	319 $6,000
Q2 2021 Aug 02, 2021	BUY	$18.04 - $22.09 $2,092 - $2,562	116 New	116 $4,000
Q2 2020 Jul 20, 2020	SELL	$27.12 - $45.97 $244 - $413	-9 Closed	0 $0
Q2 2019 Jul 23, 2019	SELL	$75.84 - $105.21 $151 - $210	-2 Reduced 18.18%	9 $1,000
Q4 2018 Jan 17, 2019	SELL	$59.1 - $93.26 $59 - $93	-1 Reduced 8.33%	11 $1,000
Q3 2018 Nov 02, 2018	SELL	$88.86 - $117.49 $266 - $352	-3 Reduced 20.0%	12 $2,000
Q2 2018 Jul 27, 2018	BUY	$99.64 - $127.59 $398 - $510	4 Added 36.36%	15 $2,000
Q2 2017 Aug 10, 2017	BUY	N/A	11	11 $1,000

20.2M

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $298M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.